Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2850 | 2058 | 35.8 | 74% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ATROPHIC GASTRITIS | Author keyword | 125 | 47% | 10% | 197 |
2 | INTESTINAL METAPLASIA | Author keyword | 79 | 29% | 11% | 233 |
3 | PEPSINOGEN | Author keyword | 39 | 32% | 5% | 102 |
4 | GASTRIC ATROPHY | Author keyword | 35 | 49% | 3% | 53 |
5 | GASTRITIS | Author keyword | 27 | 12% | 10% | 203 |
6 | PEPSINOGENS | Author keyword | 22 | 55% | 1% | 27 |
7 | CHRONIC ATROPHIC GASTRITIS | Author keyword | 21 | 40% | 2% | 41 |
8 | GASTRIC CANCER SCREENING | Author keyword | 20 | 67% | 1% | 18 |
9 | CHRONIC GASTRITIS | Author keyword | 16 | 21% | 3% | 67 |
10 | GASTRIC INTESTINAL METAPLASIA | Author keyword | 15 | 63% | 1% | 15 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ATROPHIC GASTRITIS | 125 | 47% | 10% | 197 | Search ATROPHIC+GASTRITIS | Search ATROPHIC+GASTRITIS |
2 | INTESTINAL METAPLASIA | 79 | 29% | 11% | 233 | Search INTESTINAL+METAPLASIA | Search INTESTINAL+METAPLASIA |
3 | PEPSINOGEN | 39 | 32% | 5% | 102 | Search PEPSINOGEN | Search PEPSINOGEN |
4 | GASTRIC ATROPHY | 35 | 49% | 3% | 53 | Search GASTRIC+ATROPHY | Search GASTRIC+ATROPHY |
5 | GASTRITIS | 27 | 12% | 10% | 203 | Search GASTRITIS | Search GASTRITIS |
6 | PEPSINOGENS | 22 | 55% | 1% | 27 | Search PEPSINOGENS | Search PEPSINOGENS |
7 | CHRONIC ATROPHIC GASTRITIS | 21 | 40% | 2% | 41 | Search CHRONIC+ATROPHIC+GASTRITIS | Search CHRONIC+ATROPHIC+GASTRITIS |
8 | GASTRIC CANCER SCREENING | 20 | 67% | 1% | 18 | Search GASTRIC+CANCER+SCREENING | Search GASTRIC+CANCER+SCREENING |
9 | CHRONIC GASTRITIS | 16 | 21% | 3% | 67 | Search CHRONIC+GASTRITIS | Search CHRONIC+GASTRITIS |
10 | GASTRIC INTESTINAL METAPLASIA | 15 | 63% | 1% | 15 | Search GASTRIC+INTESTINAL+METAPLASIA | Search GASTRIC+INTESTINAL+METAPLASIA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ATROPHIC GASTRITIS | 107 | 29% | 15% | 316 |
2 | SYDNEY SYSTEM | 107 | 48% | 8% | 165 |
3 | INTESTINAL METAPLASIA | 81 | 18% | 19% | 400 |
4 | CHRONIC ATROPHIC GASTRITIS | 46 | 42% | 4% | 83 |
5 | PRECANCEROUS PROCESS | 39 | 80% | 1% | 24 |
6 | SERUM PEPSINOGEN | 31 | 51% | 2% | 43 |
7 | ANTIBODY PREVALENCE | 25 | 38% | 3% | 52 |
8 | SERUM PEPSINOGEN I | 25 | 37% | 3% | 54 |
9 | STOMACH CANCER | 25 | 14% | 8% | 170 |
10 | BODY GASTRITIS | 22 | 55% | 1% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Screening for gastric cancer in Asia: current evidence and practice | 2008 | 268 | 59 | 69% |
Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer? | 2009 | 157 | 38 | 63% |
Review article: the epidemiology and prevention of gastric cancer | 2014 | 23 | 46 | 37% |
Classification and grading of gastritis - The updated Sydney System | 1996 | 2618 | 91 | 24% |
Chronic gastritis | 2015 | 1 | 65 | 78% |
Preneoplastic Conditions in the Stomach: Always a Point of No Return? | 2015 | 1 | 29 | 76% |
Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-"ABC method" | 2011 | 32 | 54 | 76% |
Diagnosis and Management of High Risk Group for Gastric Cancer | 2015 | 1 | 102 | 68% |
Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan | 2014 | 11 | 32 | 56% |
Prevalence of gastric precancerous conditions: a systematic review and meta-analysis | 2014 | 4 | 108 | 88% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIGEST DIS GASTRO | 8 | 75% | 0.3% | 6 |
2 | CANC SCREENING ASSESSMENT MANAGEMENT | 7 | 64% | 0.3% | 7 |
3 | PATHOL 113 | 4 | 50% | 0.3% | 6 |
4 | ESCUELA MED INVEST MED | 2 | 67% | 0.1% | 2 |
5 | IST ONCOL VENETO IOV IRCCS | 2 | 36% | 0.2% | 4 |
6 | CANC PREVENT MED | 2 | 26% | 0.2% | 5 |
7 | AMNCH TCD | 1 | 100% | 0.1% | 2 |
8 | BAOGANG HOSP | 1 | 50% | 0.1% | 2 |
9 | ESCUELA MED GASTROENTEROL | 1 | 100% | 0.1% | 2 |
10 | KLIN GASROENTEROL HEPATOL INFEKTOL | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000271048 | SALT TASTE PREFERENCE//24 HOUR URINE SODIUM//DIETARY REFERENCE INTAKES |
2 | 0.0000242508 | GASTRIC METAPLASIA//DUODENAL GASTRIC METAPLASIA//PARIETAL INDEX |
3 | 0.0000156741 | HELICOBACTER PYLORI//UREA BREATH TEST//C 13 UREA BREATH TEST |
4 | 0.0000151949 | CAGA//VACA//HELICOBACTER PYLORI |
5 | 0.0000116196 | ASIAN CANCER CONTROL//BUR HLTH TECHNOL RD PLANNING BUDGET MANAGEMENT//EARLY DETECT PREVENT |
6 | 0.0000111847 | GASTROINTESTINAL LIVER PATHOL//PANETH CELL//CILIATED METAPLASIA |
7 | 0.0000103667 | AUTOIMMUNE GASTRITIS//EXPERIMENTAL AUTOIMMUNE GASTRITIS//NEONATAL THYMECTOMY |
8 | 0.0000095829 | CDX2//CDX1//CDX |
9 | 0.0000090234 | HUMAN CYTOGENET TOXICOL GENET//C KI RAS ONCOGENE//JOAO BARROS BARRETO UNIV HOSP |
10 | 0.0000088158 | IL 1RN//INTERLEUKIN 1 BETA GENE//INTERLEUKIN 1B |